SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,852.90 -876.37
( -1.17%)

Global Indices

Nasdaq

51,986.54 -36.87
(-0.07%)

Dow Jones

7,712.39 31.95
(0.42%)

Hang Seng

63,869.15 -1,047.55
(-1.61%)

Nikkei 225

10,731.75 -32.94
(-0.31%)

Forex

USD-INR

94.77 -0.08
(-0.08%)

EUR-INR

106.47 0.12
(0.11%)

GBP-INR

126.26 0.54
(0.43%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9539136

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

156.23

103667.29

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.64

Back

The Ramco Cements consolidated net profit declines 63.27% in the June 2026 quarter

Aug 08,2026

Net profit of The Ramco Cements declined 63.27% to Rs 31.23 crore in the quarter ended June 2026 as against Rs 85.03 crore during the previous quarter ended June 2025. Sales rose 9.60% to Rs 2273.05 crore in the quarter ended June 2026 as against Rs 2074.02 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2273.05	2074.02	10
OPM %	13.48	19.17	-
PBDT	217.61	298.77	-27
PBT	27.77	114.87	-76
NP	31.23	85.03	-63

73,852.90 -876.37 ( -1.17%)

51,986.54 -36.87 (-0.07%)

7,712.39 31.95 (0.42%)

63,869.15 -1,047.55 (-1.61%)

10,731.75 -32.94 (-0.31%)

94.77 -0.08 (-0.08%)

106.47 0.12 (0.11%)

126.26 0.54 (0.43%)

0.60 0.00 (-0.12%)